Up Next

ki-logo-white
Market-Based Solutions to Vital Economic Issues

SEARCH

ki-logo-white
Market-Based Solutions to Vital Economic Issues

pharmaceutical

SHOW ME:

AI. CRISPR. mRNA. Key components of the rapidly expanding alphabet soup of technologies driving a boom in healthcare innovation. In this Kenan Insight, we explore why the 2021 Trends in Entrepreneurship Report names emerging technology in the healthcare industry as a key trend, along with some of the challenges that come with fast-moving technological advancements.

How have AstraZeneca's recent missteps in reporting COVID-19 vaccine clinical trial results affected the public's trust, and what's next on the road to FDA approval? Hear from Emmes Chief Business Officer Lynn Lewis.

LabCorp Executive Vice President & President of Diagnostics Brian Caveney joined UNC Kenan-Flagler Business School Associate Dean of MBA Programs & Faculty Director of the Center for the Business of Health Brad Staats on Friday, Nov. 13 for an exclusive conversation as part of the 10th Annual Business of Healthcare Conference. This virtual fireside chat was part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford.

Join the Center for the Business of Health virtually as they discuss the complexity of the healthcare ecosystem and how innovation and interconnectivity are necessary to build a more robust and flexible system.

Please join us for an exclusive conversation with LabCorp Executive Vice President & President of Diagnostics Brian Caveney on Friday, Nov. 13. This virtual fireside chat is part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford. The discussion will be led by Brad Staats, Associate Dean of MBA Programs, Professor of Operations, Sarah Graham Kenan Scholar & Faculty Director of the Center for the Business of Health.

The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.

The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.

Join the Kenan Institute of Private Enterprise and the North Carolina CEO Leadership Forum September 22 for the launch of a new report examining the state of our national economy – and exploring its future.

High rates of opioid abuse have had a significant impact on the United States including implications for firms which must now contend with a lower pool of available and productive workers. This paper documents a negative effect of instrumented opioid prescriptions and subsequent individual employment outcomes.

Venture philanthropy presents a new model of research funding that is particularly helpful to those fighting orphan diseases, which actively manages the commercialization process to accelerate scientific progress and material outcomes. This paper begins by documenting the growing importance of foundations as a source of funding academic research as traditional funding from industry and government sources decline.